Cargando…

Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease

INTRODUCTION: In this study, we examine similarities and differences between 52 patients with idiopathic normal pressure hydrocephalus (iNPH) and 17 patients with subcortical small vessel disease (SSVD), in comparison to 28 healthy controls (HCs) by a panel of cerebrospinal fluid (CSF) biomarkers. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeppsson, Anna, Bjerke, Maria, Hellström, Per, Blennow, Kaj, Zetterberg, Henrik, Kettunen, Petronella, Wikkelsø, Carsten, Wallin, Anders, Tullberg, Mats
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927666/ https://www.ncbi.nlm.nih.gov/pubmed/35309577 http://dx.doi.org/10.3389/fneur.2022.839307

Ejemplares similares

Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus
por: Grønning, Rebecca, et al.
Publicado: (2023)

CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics
por: Jeppsson, Anna, et al.
Publicado: (2019)

Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus
por: Jeppsson, A., et al.
Publicado: (2016)

Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus
por: Minta, Karolina, et al.
Publicado: (2021)

Blood‐brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein‐β in patients with subcortical small‐vessel disease
por: Kettunen, Petronella, et al.
Publicado: (2022)

Amyloid precursor like protein 1 in Idiopathic Normal Pressure hydrocephalus; expanding the knowledge of an altered amyloid metabolism
por: Jeppsson, A, et al.
Publicado: (2015)

Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus
por: Jeppsson, A., et al.
Publicado: (2023)

Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus
por: Tullberg, Mats, et al.
Publicado: (2008)

Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients
por: Lukkarinen, Heikki, et al.
Publicado: (2022)

Early shunt surgery improves survival in idiopathic normal pressure hydrocephalus
por: Andrén, Kerstin, et al.
Publicado: (2021)

The APOE Genotype in Idiopathic Normal Pressure Hydrocephalus
por: Yang, Yi, et al.
Publicado: (2016)

Survival in treated idiopathic normal pressure hydrocephalus
por: Andrén, Kerstin, et al.
Publicado: (2019)

Shunt surgery in idiopathic normal pressure hydrocephalus is cost-effective—a cost utility analysis
por: Tullberg, Mats, et al.
Publicado: (2017)

Pre-and postoperative cerebral blood flow changes in patients with idiopathic normal pressure hydrocephalus measured by computed tomography (CT)-perfusion
por: Ziegelitz, Doerthe, et al.
Publicado: (2015)

Long-term effects of complications and vascular comorbidity in idiopathic normal pressure hydrocephalus: a quality registry study
por: Andrén, Kerstin, et al.
Publicado: (2017)

Influence of vascular risk factors and vascular disease on long-term outcome in idiopathic Normal Pressure Hydrocephalus; a Quality Registry based study
por: Andrén, Kerstin, et al.
Publicado: (2015)

Predicting neuropsychological outcome following shunt operation in iNPH using reliable change indices (RCIs)
por: Wallin, Maria, et al.
Publicado: (2015)

Neuropsychological effects of shunting in iNPH – determining major and minor responses
por: Wallin, Maria, et al.
Publicado: (2015)

Physical exercise and goal attainment after shunt surgery in idiopathic normal pressure hydrocephalus: a randomised clinical trial
por: Rydja, Johanna, et al.
Publicado: (2021)

The role of hypertension and diabetes mellitus in the severity of gait and balance disturbances in iNPH
por: Agerskov, Simon, et al.
Publicado: (2015)

Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease(2)
por: Wallin, Anders, et al.
Publicado: (2018)

MRI diffusion and perfusion alterations in the mesencephalon and pons as markers of disease and symptom reversibility in idiopathic normal pressure hydrocephalus
por: Agerskov, Simon, et al.
Publicado: (2020)

Physical Capacity and Activity in Patients With Idiopathic Normal Pressure Hydrocephalus
por: Rydja, Johanna, et al.
Publicado: (2022)

Cardiovascular risk factors are associated with Idiopathic Normal Pressure Hydrocephalus
por: Israelsson, Hanna, et al.
Publicado: (2015)

Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies
por: Wallin, Anders, et al.
Publicado: (2016)

A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer’s Disease
por: Andersson, Carl-Henrik, et al.
Publicado: (2016)

Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease
por: Mattsson, Niklas, et al.
Publicado: (2010)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
por: Skillbäck, Tobias, et al.
Publicado: (2013)

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer's Disease
por: Öhrfelt, Annika, et al.
Publicado: (2011)

Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
por: Johansson, Per, et al.
Publicado: (2013)

Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury
por: Minta, Karolina, et al.
Publicado: (2020)

Shunt surgery in iNPH patients is cost-effective – a cost-utility analysis in the Western Sweden setting
por: Tullberg, Mats, et al.
Publicado: (2015)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
por: Blennow, Kaj, et al.
Publicado: (2015)

Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus
por: Weiner, Sophia, et al.
Publicado: (2023)

The timed up and go test in idiopathic normal pressure hydrocephalus: a Nationwide Study of 1300 patients
por: Sundström, Nina, et al.
Publicado: (2022)

Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus
por: Braun, Madelene, et al.
Publicado: (2022)

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection
por: Bremell, Daniel, et al.
Publicado: (2013)

CSF Biomarkers Predict Gait Outcomes in Idiopathic Normal Pressure Hydrocephalus
por: Darrow, Jacqueline A., et al.
Publicado: (2022)

Alzheimer’s Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus
por: Mazzeo, Salvatore, et al.
Publicado: (2022)

Neurological Assessment and Its Relationship to CSF Biomarkers in Amateur Boxers
por: Neselius, Sanna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kdnfucr9d2n2hlfq4epk2589mi